Edition:
India

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,880JPY
7:19am IST
Change (% chg)

¥30 (+0.51%)
Prev Close
¥5,850
Open
¥5,850
Day's High
¥5,880
Day's Low
¥5,830
Volume
24,400
Avg. Vol
157,224
52-wk High
¥6,970
52-wk Low
¥5,410

Summary

Name Age Since Current Position

Tetsuo Ohnuma

67 2011 President, Representative Director

Hirokazu Konishi

64 2017 Managing Director

Jun Takaoka

62 2016 Managing Director

Hiroyuki Horiuchi

55 2017 Chief Director of Sales, Director

Jumpei Suzuki

2016 Executive Officer, Director of Accounting

Satoru Murakami

2016 Executive Officer, Director of Pharmaceutical Affairs, Manager of Pharmaceutical Manufacturing

Kenichi Nakamura

2016 Executive Officer, Director of General Affairs

Norihide Oizumi

Executive Officer

Toshiyuki Takahashi

2016 Executive Officer, Director of Sales Planning

Chikara Ieda

56 2017 Chief Director of Research & Development, Director

Fumihiro Watanabe

57 2016 Director

Eiki Enomoto

48 2014 Non-Executive Independent Director

Yoshio Tanabe

62 2016 Non-Executive Independent Director

Biographies

Name Description

Tetsuo Ohnuma

Mr. Tetsuo Ohnuma has been serving as President and Representative Director of Kaken Pharmaceutical Co., Ltd. since June 2011. He joined the Company in April 1974. His previous titles include Director of Sales Planning, Executive Officer, Managing Director and Chief Director of Sales in the Company.

Hirokazu Konishi

Mr. Hirokazu Konishi has been serving as Managing Director in Kaken Pharmaceutical Co., Ltd. since 2017. He joined the Company in April 1977. His previous titles include Director of Sales Planning, Manager of Sapporo Office and Manager of 2nd Tokyo Office in the Company.

Jun Takaoka

Mr. Jun Takaoka has been serving as Managing Director of Kaken Pharmaceutical Co., Ltd. since June 2016. He used to work for The Norinchukin Bank, Nihon Unisys, Ltd. and Okasan Securities Co., Ltd.

Hiroyuki Horiuchi

Mr. Hiroyuki Horiuchi has been serving as Chief Director of Sales and Director in Kaken Pharmaceutical Co., Ltd. since April 2017. He joined the Company in April 1984. His previous titles include Executive Officer, Manager of Chugoku & Shikoku Office and Manager of Osaka Office in the Company.

Jumpei Suzuki

Satoru Murakami

Kenichi Nakamura

Norihide Oizumi

Toshiyuki Takahashi

Chikara Ieda

Mr. Chikara Ieda has been serving as Chief Director of Research & Development and Director in Kaken Pharmaceutical Co., Ltd. since June 2017. He joined the Company in April 1984. His previous titles include Director of Clinical Development, Director of Expansion Planning, Director of Development Portfolio Promotion and Executive Officer in the Company.

Fumihiro Watanabe

Mr. Fumihiro Watanabe has been serving as Director of Kaken Pharmaceutical Co., Ltd. since June 2016. He joined the Company in April 2000. His previous titles include Executive Officer, Director of General Affairs and Director of Accounting in the Company. He used to work for Toho Mutual Life Insurance Company.

Eiki Enomoto

Mr. Eiki Enomoto has been serving as Non-Executive Independent Director in Kaken Pharmaceutical Co., Ltd. since June 27, 2014. He is also serving as Partner in a Japan-based law firm. He used to work for Zenrin Company, Limited.

Yoshio Tanabe

Mr. Yoshio Tanabe has been serving as Non-Executive Independent Director in Kaken Pharmaceutical Co., Ltd. since June 2016. He is also serving as Partner in KIZASHI Co., Ltd. He used to work for McKinsey & Company, Inc., Otsuka Pharmaceutical Co., Ltd. and TOKUHON Corporation.